Berlin Institute of Health at Charite (BIH)

The mission of the Berlin Institute of Health (BIH) is medical translation: transferring biomedical research findings into novel approaches to personalized prediction, prevention, diagnostics and therapy and, conversely, using clinical observations to develop new research ideas. The aim is to deliver relevant medical benefits to patients and the population at large. The BIH is also committed to establishing a comprehensive translational ecosystem as translational research unit at Charite – one that places emphasis on a system-wide understanding of health and disease and that promotes change in the biomedical research culture. The BIH was founded in 2013 and is funded 90 percent by the Federal Ministry of Education and Research (BMBF) and 10 percent by the State of Berlin. The two founding institutions, Charite - Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), were independent member entities within the BIH until 2020. As of 2021, the BIH has been integrated into Charite as its third pillar, the so-called translational research unit; the MDC is privileged partner of the BIH.